Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Search results

Found 188 matches for

The COVID-19 National Diagnostic Research and Evaluation Platform (CONDOR) is accelerating how quickly promising COVID-19 diagnostics make it into real-world use. The platform is evaluating new COVID-19 diagnostics in the settings they will be used, such as in GP surgeries, care homes or hospitals, as well as their performance in laboratory settings.

The Conversation: Why we need to test COVID-19 tests

General

During the first peak of the coronavirus pandemic, it became apparent that the processing of the standard COVID-19 test using nasal swab samples, while considered a gold standard, was slow, taking over 24 hours to give results in most cases.

Helping to prioritise rapid COVID-19 testing in UK hospitals

Publication

Working with CONDOR partners the Newcastle In Vitro Diagnostics Co-operative have analysed clinical opinion to pinpoint where rapid COVID-19 testing could have the greatest impact in UK hospitals.

Webinar: Prioritising the evaluation of novel coronavirus diagnostics in the UK

Are you from a diagnostics company and keen to know more about CONDOR? The NIHR is holding a webinar on Wed 15 July where you can learn how the UK is prioritising and evaluating novel coronavirus IVDs and ensure your diagnostic gets the visibility and support it needs.

CONDOR platform launches

New £1.3 million national research programme to evaluate coronavirus tests in hospitals, GP surgeries and care homes